MARK G FOLETTA Insider Trading $AMLN AMYLIN PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK G FOLETTA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK G FOLETTA. MARK G FOLETTA is Senior VP, Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP & Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Director in AMN HEALTHCARE SERVICES INC ($AHS) and Director in DEXCOM INC ($DXCM) and Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Interim CFO in BIOCEPT INC ($BIOC) and EVP & Chief Financial Officer in Tocagen Inc ($TOCA) and Director in Regulus Therapeutics Inc. ($RGLS).
MARK G FOLETTA in AMYLIN PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: SVP, Chief Financial Officer, SVP Chief Financial Officer, Sr VP Finance & CFO, Senior VP, Finance & CFO, VP Finance & CFO, VP & Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Aug 10 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK G FOLETTA in AMYLIN PHARMACEUTICALS INC
Sentiment: All, AHS, AMLN, BIOC, DXCM, ENTA, TOCA, RGLS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 43.91 | 291 | 12,778 | 27,048 | 27.3 K to 27 K (-1.06 %) |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 291 | 1,667 | 27,339 | 27 K to 27.3 K (+1.08 %) |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 1,500 | 8,595 | 291 | |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 37.70 | 1,500 | 56,550 | 27,048 | 28.5 K to 27 K (-5.25 %) |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 1,500 | 8,595 | 28,548 | 27 K to 28.5 K (+5.55 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Grant | A | 19.46 | 286 | 5,565 | 27,048 | 26.8 K to 27 K (+1.07 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Grant | A | 39.92 | 264 | 10,539 | 26,762 | 26.5 K to 26.8 K (+1.00 %) |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 2,000 | 11,460 | 1,791 | |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 43.00 | 2,000 | 86,000 | 26,498 | 28.5 K to 26.5 K (-7.02 %) |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 2,000 | 11,460 | 28,498 | 26.5 K to 28.5 K (+7.55 %) |
| Dec 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,333 | 19,098 | 3,791 | |
| Dec 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 38.75 | 3,333 | 129,154 | 26,498 | 29.8 K to 26.5 K (-11.17 %) |
| Dec 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,333 | 19,098 | 29,831 | 26.5 K to 29.8 K (+12.58 %) |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,333 | 19,098 | 7,124 | |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 34.35 | 3,333 | 114,489 | 26,498 | 29.8 K to 26.5 K (-11.17 %) |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,333 | 19,098 | 29,831 | 26.5 K to 29.8 K (+12.58 %) |
| Oct 17 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,333 | 19,098 | 10,457 | |
| Oct 17 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 36.40 | 3,333 | 121,321 | 26,498 | 29.8 K to 26.5 K (-11.17 %) |
| Oct 17 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,333 | 19,098 | 29,831 | 26.5 K to 29.8 K (+12.58 %) |
| Oct 07 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 4,375 | 25,069 | 0 | |
| Oct 07 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Payment of Exercise | F | 35.56 | 704 | 25,034 | 26,498 | 27.2 K to 26.5 K (-2.59 %) |
| Oct 07 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 4,375 | 25,069 | 27,202 | 22.8 K to 27.2 K (+19.17 %) |
| May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | A | 16.54 | 35,475 | 586,757 | 35,475 | |
| May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | A | 16.54 | 4,525 | 74,844 | 4,525 | |
| Apr 01 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 2,195 | 12,577 | 4,375 | |
| Apr 01 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 2,195 | 12,577 | 22,704 | 20.5 K to 22.7 K (+10.70 %) |
| Jan 03 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,000 | 17,190 | 13,790 | |
| Jan 03 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 23.50 | 3,000 | 70,500 | 19,262 | 22.3 K to 19.3 K (-13.48 %) |
| Jan 03 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,000 | 17,190 | 22,262 | 19.3 K to 22.3 K (+15.57 %) |
| Nov 30 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,000 | 17,190 | 16,790 | |
| Nov 30 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 20.35 | 3,000 | 61,050 | 19,262 | 22.3 K to 19.3 K (-13.48 %) |
| Nov 30 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,000 | 17,190 | 22,262 | 19.3 K to 22.3 K (+15.57 %) |
| Nov 01 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,000 | 17,190 | 19,790 | |
| Nov 01 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 21.05 | 3,000 | 63,143 | 19,262 | 22.3 K to 19.3 K (-13.48 %) |
| Nov 01 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,000 | 17,190 | 22,262 | 19.3 K to 22.3 K (+15.57 %) |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Option Exercise | M | 9.88 | 2,190 | 21,626 | 4,810 | |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Option Exercise | M | 9.63 | 100 | 963 | 0 | |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Option Exercise | M | 5.73 | 640 | 3,667 | 6,570 | |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Payment of Exercise | F | 21.87 | 167 | 3,652 | 19,262 | 19.4 K to 19.3 K (-0.86 %) |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Buy | M | 5.73 | 640 | 3,667 | 19,429 | 18.8 K to 19.4 K (+3.41 %) |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Payment of Exercise | F | 21.87 | 44 | 962 | 18,789 | 18.8 K to 18.8 K (-0.23 %) |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Buy | M | 9.63 | 100 | 963 | 18,833 | 18.7 K to 18.8 K (+0.53 %) |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Payment of Exercise | F | 21.87 | 988 | 21,608 | 18,733 | 19.7 K to 18.7 K (-5.01 %) |
| Sep 03 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Buy | M | 9.88 | 2,190 | 21,626 | 19,721 | 17.5 K to 19.7 K (+12.49 %) |
| May 06 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Option Exercise | A | 22.60 | 34,884 | 788,378 | 34,884 | |
| May 06 2004 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP & Chief Financia ... | Option Exercise | A | 22.60 | 5,116 | 115,622 | 5,116 |